Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commissioner McClellan’s First FDA Appropriations Hearing, In Brief

Executive Summary

Generic drug rule: FDA expects to finalize proposed changes to Waxman/Hatch patent challenge procedures by spring, Commissioner McClellan tells House Appropriations/Agriculture Subcommittee hearing March 6. President Bush announced the rule in October (1"The Pink Sheet" Oct. 28, 2002, p. 3)....Generic drug education: "Let me ask you about the issue of doctors not really knowing the costs of prescription medications and what a patient might have to pay out of pocket for that drug," Rep. Jo Ann Emerson (R-Mo.) said. "If we were to make necessary funds available would you all consider expanding the current generic drug education program to target medical schools or teaching hospitals?" McClellan responded: "That would be something we could do with additional funds." Last year, FDA launched an educational campaign to encourage the use of generics (2"The Pink Sheet" July 29, 2002, p. 21)...
Advertisement

Related Content

Bush Generic Drug Reform Proposal Unlikely To End Push For Legislation
Bush Generic Drug Reform Proposal Unlikely To End Push For Legislation
DTC Is Not Improving, Rep. Waxman Says: Viagra Ads Show “Six” Sells?
FDA Generic Drug Promotional Campaign Features Newspaper Articles
Advertisement
UsernamePublicRestriction

Register

PS041386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel